Bachem – Leading partner in tides
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides.
With over 50 years of experience and expertise Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.
Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange. For further information, visit the Bachem website: https://bit.ly/3Chhss7.
CMC development
With more than 50 years of experience in the development, production, and regulatory support of peptide active pharmaceutical ingredients (API) for our customers, Bachem has long-term expertise in chemistry manufacturing and controls (CMC) development.
Commercial APIs
Bachem produces one of the largest amounts of commercially available synthetic peptide active pharmaceutical ingredients (API) in the world. From the 80 approved peptide API in new chemical entities (NCEs) and generics that are globally available, Bachem commercialized one third of these API.
Research & Specialties
Our life science research products portfolio enables you to take advantage of our well-established experience. We have a strong track record in supporting our partners in various fields and can provide tailored solutions for your peptide applications.
Bachem – Leading partner in tides
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides.
With over 50 years of experience and expertise Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.
Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange. For further information, visit the Bachem website: https://bit.ly/3Chhss7.
CMC development
With more than 50 years of experience in the development, production, and regulatory support of peptide active pharmaceutical ingredients (API) for our customers, Bachem has long-term expertise in chemistry manufacturing and controls (CMC) development.
Commercial APIs
Bachem produces one of the largest amounts of commercially available synthetic peptide active pharmaceutical ingredients (API) in the world. From the 80 approved peptide API in new chemical entities (NCEs) and generics that are globally available, Bachem commercialized one third of these API.
Research & Specialties
Our life science research products portfolio enables you to take advantage of our well-established experience. We have a strong track record in supporting our partners in various fields and can provide tailored solutions for your peptide applications.
Bachem – Leading partner in tides
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides.
With over 50 years of experience and expertise Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services.
Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange. For further information, visit the Bachem website: https://bit.ly/3Chhss7.
CMC development
With more than 50 years of experience in the development, production, and regulatory support of peptide active pharmaceutical ingredients (API) for our customers, Bachem has long-term expertise in chemistry manufacturing and controls (CMC) development.
Commercial APIs
Bachem produces one of the largest amounts of commercially available synthetic peptide active pharmaceutical ingredients (API) in the world. From the 80 approved peptide API in new chemical entities (NCEs) and generics that are globally available, Bachem commercialized one third of these API.
Research & Specialties
Our life science research products portfolio enables you to take advantage of our well-established experience. We have a strong track record in supporting our partners in various fields and can provide tailored solutions for your peptide applications.